Found: 21
Select item for more details and to access through your institution.
Targeted Mobilisation of Endogenous Endothelial Progenitor Cells — an Alternate Approach to Allogeneic Therapy for Ischaemic Cardiovasular Disease?
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 839, doi. 10.1007/s10557-023-07462-z
- By:
- Publication type:
- Article
Trimetazidine to Reduce Myocardial Fibrosis—Competing Interests with SGLT2 Inhibitors?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Reply to the Letter to the Editor Titled "The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?" by Han et al.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 845, doi. 10.1007/s10557-022-07376-2
- By:
- Publication type:
- Article
The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
CXCR7 Agonist TC14012 Improves Angiogenic Function of Endothelial Progenitor Cells via Activating Akt/eNOS Pathway and Promotes Ischemic Angiogenesis in Diabetic Limb Ischemia.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 849, doi. 10.1007/s10557-022-07337-9
- By:
- Publication type:
- Article
Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 865, doi. 10.1007/s10557-022-07345-9
- By:
- Publication type:
- Article
CircPCNX Promotes PDGF-BB-Induced Proliferation and Migration of Human Aortic Vascular Smooth Muscle Cells Through Regulating miR-1278/DNMT1 Axis.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 877, doi. 10.1007/s10557-022-07342-y
- By:
- Publication type:
- Article
Mesenchymal Stem Cell–Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 891, doi. 10.1007/s10557-022-07339-7
- By:
- Publication type:
- Article
Comparison of Evolocumab and Ezetimibe, Both Combined with Statin Therapy, for Patients with Recent Acute Coronary Syndrome: A Cost-Effectiveness Analysis from the Chinese Healthcare Perspective.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 905, doi. 10.1007/s10557-021-07276-x
- By:
- Publication type:
- Article
Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 917, doi. 10.1007/s10557-022-07346-8
- By:
- Publication type:
- Article
Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 927, doi. 10.1007/s10557-022-07338-8
- By:
- Publication type:
- Article
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 941, doi. 10.1007/s10557-022-07343-x
- By:
- Publication type:
- Article
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 955, doi. 10.1007/s10557-022-07340-0
- By:
- Publication type:
- Article
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 965, doi. 10.1007/s10557-022-07347-7
- By:
- Publication type:
- Article
Antiplatelet Therapy in End-stage Renal Disease Patients on Maintenance Dialysis: a State-of-the-art Review.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 975, doi. 10.1007/s10557-022-07366-4
- By:
- Publication type:
- Article
SGLT2-Inhibitors on HFpEF Patients. Role of Ejection Fraction.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 989, doi. 10.1007/s10557-022-07371-7
- By:
- Publication type:
- Article
Mechanobiology of the endothelium in vascular health and disease: in vitro shear stress models.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 997, doi. 10.1007/s10557-022-07385-1
- By:
- Publication type:
- Article
Considerations for Left Atrial Appendage Occlusion During Cardiac Surgery.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 1011, doi. 10.1007/s10557-022-07415-y
- By:
- Publication type:
- Article
Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 1021, doi. 10.1007/s10557-022-07341-z
- By:
- Publication type:
- Article
Long-term Dexamethasone Treatment Increases Cardiac Galectin-3 Levels.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 1027, doi. 10.1007/s10557-022-07344-w
- By:
- Publication type:
- Article
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 1031, doi. 10.1007/s10557-021-07302-y
- By:
- Publication type:
- Article